{"id":53033,"date":"2023-01-18T14:02:30","date_gmt":"2023-01-18T13:02:30","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/acro-publishes-newest-landscape-survey-results-risk-based-quality-management-in-clinical-trials\/"},"modified":"2023-01-18T14:02:30","modified_gmt":"2023-01-18T13:02:30","slug":"acro-publishes-newest-landscape-survey-results-risk-based-quality-management-in-clinical-trials","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/acro-publishes-newest-landscape-survey-results-risk-based-quality-management-in-clinical-trials\/","title":{"rendered":"ACRO Publishes Newest Landscape Survey Results: Risk-Based Quality Management in Clinical Trials"},"content":{"rendered":"
\n

WASHINGTON–(BUSINESS WIRE)–#Brexit<\/a>–This week, the Association of Clinical Research Organizations (ACRO)\u2019s RBQM Working Group published a paper in DIA\u2019s Therapeutic Innovation & Regulatory Science journal titled, Risk-Based Monitoring in Clinical Trials: 2021 Update<\/a><\/b>.\n<\/p>\n

<\/a><\/p>\n

\nFor the past three years, ACRO\u2019s RBQM Working Group has conducted an annual landscape survey of member company CROs to determine how remote monitoring and risk-based quality management processes are being implemented across the industry. The group looked at adoption rates of remote monitoring, quality tolerance limits (QTLs), centralized monitoring, and several other components. This paper details the latest findings, drawing on collected data on 5,000+ ongoing clinical trials for each of the past three years.\n<\/p>\n

\nACRO\u2019s first survey project started the year prior to the COVID-19 pandemic. As a result, the subsequent two years provide a unique perspective on how adoption rates of remote- and risk-based approaches have changed and evolved through the pandemic, and over time.\n<\/p>\n

\n\u201cThe ACRO team worked together to gather this data for a third consecutive year, and we believe it\u2019s telling in how clinical trials are currently being operationalized and will be run in the years to come,\u201d said the RBQM Working Group\u2019s lead, Brian Barnes, RBQM Strategy Specialist at Medidata Solutions.\n<\/p>\n

\nWith the continued impact of the pandemic on how clinical trials are designed and executed and the increasing number of partially or fully decentralized clinical trials (DCTs), ACRO\u2019s RBQM Working Group expects these adoption rates to continue to increase over time.\n<\/p>\n

\nBy sharing this data, the CROs and technology providers of ACRO hope to continue collaborating across all stakeholders, from ACRO members, to sponsors and regulators to make collective progress towards advancing how clinical trials are conducted most effectively and efficiently.\n<\/p>\n

\nThe paper and other resources from ACRO\u2019s RBQM Working Group can be found on the ACRO website: https:\/\/www.acrohealth.org\/risk-based-quality-management\/<\/a>.\n<\/p>\n

\nAbout ACRO<\/b>\n<\/p>\n

\nThe Association of Clinical Research Organizations (ACRO) represents clinical research and technology companies that provide a variety of specialized services to support the development of new pharmaceuticals, biologics, and medical devices. Through its member companies, ACRO helps improve the quality, efficiency, and safety of biomedical research. ACRO member companies operate in more than 100 countries across the globe and conduct or support the conduct of the majority of industry-sponsored clinical trials worldwide.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nAnina Adelfio
\n
aadelfio@acrohealth.org<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

WASHINGTON–(BUSINESS WIRE)–#Brexit–This week, the Association of Clinical Research Organizations (ACRO)\u2019s RBQM Working Group published a paper in DIA\u2019s Therapeutic Innovation & Regulatory Science journal titled, Risk-Based Monitoring in Clinical Trials: 2021 Update. For the past three years, ACRO\u2019s RBQM Working Group has conducted an annual landscape survey of member company CROs to determine how remote … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-53033","6":"format-standard","7":"category-industry"},"yoast_head":"\nACRO Publishes Newest Landscape Survey Results: Risk-Based Quality Management in Clinical Trials - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/acro-publishes-newest-landscape-survey-results-risk-based-quality-management-in-clinical-trials\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ACRO Publishes Newest Landscape Survey Results: Risk-Based Quality Management in Clinical Trials - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"WASHINGTON–(BUSINESS WIRE)–#Brexit–This week, the Association of Clinical Research Organizations (ACRO)\u2019s RBQM Working Group published a paper in DIA\u2019s Therapeutic Innovation & Regulatory Science journal titled, Risk-Based Monitoring in Clinical Trials: 2021 Update. For the past three years, ACRO\u2019s RBQM Working Group has conducted an annual landscape survey of member company CROs to determine how remote ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/acro-publishes-newest-landscape-survey-results-risk-based-quality-management-in-clinical-trials\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-01-18T13:02:30+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230118005223\/en\/692747\/21\/ACRO-logo-blue-name_full.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/acro-publishes-newest-landscape-survey-results-risk-based-quality-management-in-clinical-trials\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/acro-publishes-newest-landscape-survey-results-risk-based-quality-management-in-clinical-trials\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"ACRO Publishes Newest Landscape Survey Results: Risk-Based Quality Management in Clinical Trials\",\"datePublished\":\"2023-01-18T13:02:30+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/acro-publishes-newest-landscape-survey-results-risk-based-quality-management-in-clinical-trials\\\/\"},\"wordCount\":403,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/acro-publishes-newest-landscape-survey-results-risk-based-quality-management-in-clinical-trials\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230118005223\\\/en\\\/692747\\\/21\\\/ACRO-logo-blue-name_full.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/acro-publishes-newest-landscape-survey-results-risk-based-quality-management-in-clinical-trials\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/acro-publishes-newest-landscape-survey-results-risk-based-quality-management-in-clinical-trials\\\/\",\"name\":\"ACRO Publishes Newest Landscape Survey Results: Risk-Based Quality Management in Clinical Trials - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/acro-publishes-newest-landscape-survey-results-risk-based-quality-management-in-clinical-trials\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/acro-publishes-newest-landscape-survey-results-risk-based-quality-management-in-clinical-trials\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230118005223\\\/en\\\/692747\\\/21\\\/ACRO-logo-blue-name_full.jpg\",\"datePublished\":\"2023-01-18T13:02:30+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/acro-publishes-newest-landscape-survey-results-risk-based-quality-management-in-clinical-trials\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/acro-publishes-newest-landscape-survey-results-risk-based-quality-management-in-clinical-trials\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/acro-publishes-newest-landscape-survey-results-risk-based-quality-management-in-clinical-trials\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230118005223\\\/en\\\/692747\\\/21\\\/ACRO-logo-blue-name_full.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230118005223\\\/en\\\/692747\\\/21\\\/ACRO-logo-blue-name_full.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/acro-publishes-newest-landscape-survey-results-risk-based-quality-management-in-clinical-trials\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"ACRO Publishes Newest Landscape Survey Results: Risk-Based Quality Management in Clinical Trials\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"ACRO Publishes Newest Landscape Survey Results: Risk-Based Quality Management in Clinical Trials - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/acro-publishes-newest-landscape-survey-results-risk-based-quality-management-in-clinical-trials\/","og_locale":"en_US","og_type":"article","og_title":"ACRO Publishes Newest Landscape Survey Results: Risk-Based Quality Management in Clinical Trials - Pharma Trend","og_description":"WASHINGTON–(BUSINESS WIRE)–#Brexit–This week, the Association of Clinical Research Organizations (ACRO)\u2019s RBQM Working Group published a paper in DIA\u2019s Therapeutic Innovation & Regulatory Science journal titled, Risk-Based Monitoring in Clinical Trials: 2021 Update. For the past three years, ACRO\u2019s RBQM Working Group has conducted an annual landscape survey of member company CROs to determine how remote ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/acro-publishes-newest-landscape-survey-results-risk-based-quality-management-in-clinical-trials\/","og_site_name":"Pharma Trend","article_published_time":"2023-01-18T13:02:30+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230118005223\/en\/692747\/21\/ACRO-logo-blue-name_full.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/acro-publishes-newest-landscape-survey-results-risk-based-quality-management-in-clinical-trials\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/acro-publishes-newest-landscape-survey-results-risk-based-quality-management-in-clinical-trials\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"ACRO Publishes Newest Landscape Survey Results: Risk-Based Quality Management in Clinical Trials","datePublished":"2023-01-18T13:02:30+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/acro-publishes-newest-landscape-survey-results-risk-based-quality-management-in-clinical-trials\/"},"wordCount":403,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/acro-publishes-newest-landscape-survey-results-risk-based-quality-management-in-clinical-trials\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230118005223\/en\/692747\/21\/ACRO-logo-blue-name_full.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/acro-publishes-newest-landscape-survey-results-risk-based-quality-management-in-clinical-trials\/","url":"https:\/\/pharma-trend.com\/en\/acro-publishes-newest-landscape-survey-results-risk-based-quality-management-in-clinical-trials\/","name":"ACRO Publishes Newest Landscape Survey Results: Risk-Based Quality Management in Clinical Trials - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/acro-publishes-newest-landscape-survey-results-risk-based-quality-management-in-clinical-trials\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/acro-publishes-newest-landscape-survey-results-risk-based-quality-management-in-clinical-trials\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230118005223\/en\/692747\/21\/ACRO-logo-blue-name_full.jpg","datePublished":"2023-01-18T13:02:30+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/acro-publishes-newest-landscape-survey-results-risk-based-quality-management-in-clinical-trials\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/acro-publishes-newest-landscape-survey-results-risk-based-quality-management-in-clinical-trials\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/acro-publishes-newest-landscape-survey-results-risk-based-quality-management-in-clinical-trials\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230118005223\/en\/692747\/21\/ACRO-logo-blue-name_full.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230118005223\/en\/692747\/21\/ACRO-logo-blue-name_full.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/acro-publishes-newest-landscape-survey-results-risk-based-quality-management-in-clinical-trials\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"ACRO Publishes Newest Landscape Survey Results: Risk-Based Quality Management in Clinical Trials"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/53033","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=53033"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/53033\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=53033"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=53033"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=53033"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}